Evaluation of radiofrequency therapy effectiveness on sexual dysfunction

Evaluation of Radiofrequency Therapy Effectiveness on Sexual Dysfunction in Female Cancer Survivors (Gynecologic & Breast) Compared to Non-cancer Menopause Subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160531028187N2

Enrollment

Registered

2022-11-19

Start date

2022-11-22

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual dysfunction. Sexual dysfunction, unspecified

Interventions

Intervention 1: Intervention group 1: Patient with cancer refers three times with an interval of one month. The plate is placed under the patient's buttocks. It works on the external genitalia for 10

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Sexually active postmenopausal women Patients with malignancy 3 months after completing treatment

Exclusion criteria

Exclusion criteria: Hormone therapy (systemic or topical) or other treatments for sexual dysfunction (such as moisturizers) Mild sexual dysfunction (score above 28 according to the questionnaire) Patients with active or recurrent genital tract infection (such as herpes or candida infection) People infected with HIV Urinary tract infection Pelvic reconstructive surgery Having a pacemaker Having intra-uterine device Pregnancy Breast feeding Skin diseases Not signing the informed consent form

Design outcomes

Primary

Measure	Time frame
Dyspareunia. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Sexual Desire. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Sexual Arousal. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Sexual Satisfaction. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Sexual Lubrication. Timepoint: Before the intervention and three months after the Intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Orgasm. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.	—

Measure

Time frame

Dyspareunia. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Sexual Desire. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Sexual Arousal. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Sexual Satisfaction. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Sexual Lubrication. Timepoint: Before the intervention and three months after the Intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.;Orgasm. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Female Sexual Function Index Scoring questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahshid Vasef

Shahid Beheshti University of Medical Sciences

mahshid.vasef81@gmail.com+98 21 7343 3000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026